Global Proton Pump Inhibitors (PPI) Market Size, Share & Trends Analysis Report, by Type (Esomeprazole, Omeprazole, Pantoprazole, Dexlansoprazole, Rabeprazole, Lansoprazole and other), by Administration (Over the Counter and Prescription) and Forecast Period, 2020-2026
The global proton pump inhibitors market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma have a higher risk of developing GERD. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand for novel delivery systems accelerating the market growth.
The global proton pump inhibitors market is segmented based on type and administration. Based on type, the market is classified into esomeprazole, omeprazole, dexlansoprazole, pantoprazole, rabeprazole, lansoprazole, and other. Based on administration, the market is classified into OTC and prescription. Pfizer recommended Nexium as an OTC product in most of the European countries such as France, Germany, and Italy due to increase in the consumption of esomeprazole drug. Geographically, the global Proton Pump Inhibitors market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. Due to the increase in the number of gastrointestinal problems and the continuous production of new product is accelerating the market.
The major companies providing PPI include AstraZeneca PLC, Takeda Pharmaceuticals Co. Ltd., Pfizer, Inc., Bayer AG, Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.), Aurobindo Pharma, Ltd., Eisai Co., Ltd., Procter & Gamble Co., and Sanofi S.A. These players adopt various strategies in order to stay competitive in the market and expand their market share.
Research Methodology
The market study of the global PPI market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity tthe reports.
Secondary Sources Include:
The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
The Report Covers:
The global proton pump inhibitors market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma have a higher risk of developing GERD. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand for novel delivery systems accelerating the market growth.
The global proton pump inhibitors market is segmented based on type and administration. Based on type, the market is classified into esomeprazole, omeprazole, dexlansoprazole, pantoprazole, rabeprazole, lansoprazole, and other. Based on administration, the market is classified into OTC and prescription. Pfizer recommended Nexium as an OTC product in most of the European countries such as France, Germany, and Italy due to increase in the consumption of esomeprazole drug. Geographically, the global Proton Pump Inhibitors market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. Due to the increase in the number of gastrointestinal problems and the continuous production of new product is accelerating the market.
The major companies providing PPI include AstraZeneca PLC, Takeda Pharmaceuticals Co. Ltd., Pfizer, Inc., Bayer AG, Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.), Aurobindo Pharma, Ltd., Eisai Co., Ltd., Procter & Gamble Co., and Sanofi S.A. These players adopt various strategies in order to stay competitive in the market and expand their market share.
Research Methodology
The market study of the global PPI market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.
In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity tthe reports.
Secondary Sources Include:
- Financial reports of companies involved in the market.
- Authentic public databases
- Whitepapers, research-papers, and news blogs.
- Company websites and their product catalog.
The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation:
- Global Proton Pump Inhibitors Market Research and Analysis by Type
- Global Proton Pump Inhibitors Market Research and Analysis by Administration
The Report Covers:
- Comprehensive research methodologies of the global proton pump inhibitors market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global proton pump inhibitors market.
- Insights about market determinants which are stimulating the global proton pump inhibitors market.
- Detailed and extensive market segments with regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Table of Contents
1. Report Summary
2. Market Overview and Insights
3. Competitive Landscape
4. Market Determinants
5. Market Segmentation
6. Regional Analysis
7. Company Profiles
Companies Mentioned
A selection of companies mentioned in this report includes:
- Alkem Laboratories, Ltd.
- AstraZeneca PLC
- Aurobindo Pharma, Ltd.
- Bayer AG
- Cadila Healthcare, Ltd.
- Chongqing LUMMY Pharmaceutical Co., Ltd.
- Eisai Co., Ltd.
- GlaxoSmithKline PLC
- Glenmark Pharmaceuticals, Inc.
- Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
- Lannett Company, Inc.
- Novartis AG
- Pfizer, Inc.
- Procter & Gamble Co.
- Sanofi S.A.
- Sun Pharmaceutical Industries, Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceuticals Industries, Ltd.